1. Home
  2. RYAM vs GOSS Comparison

RYAM vs GOSS Comparison

Compare RYAM & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYAM
  • GOSS
  • Stock Information
  • Founded
  • RYAM 1926
  • GOSS 2015
  • Country
  • RYAM United States
  • GOSS United States
  • Employees
  • RYAM N/A
  • GOSS N/A
  • Industry
  • RYAM Paper
  • GOSS Biotechnology: Pharmaceutical Preparations
  • Sector
  • RYAM Basic Materials
  • GOSS Health Care
  • Exchange
  • RYAM Nasdaq
  • GOSS Nasdaq
  • Market Cap
  • RYAM 477.7M
  • GOSS 501.2M
  • IPO Year
  • RYAM N/A
  • GOSS 2019
  • Fundamental
  • Price
  • RYAM $5.90
  • GOSS $2.72
  • Analyst Decision
  • RYAM Buy
  • GOSS Strong Buy
  • Analyst Count
  • RYAM 1
  • GOSS 6
  • Target Price
  • RYAM $6.00
  • GOSS $8.60
  • AVG Volume (30 Days)
  • RYAM 683.3K
  • GOSS 2.9M
  • Earning Date
  • RYAM 11-04-2025
  • GOSS 11-05-2025
  • Dividend Yield
  • RYAM N/A
  • GOSS N/A
  • EPS Growth
  • RYAM N/A
  • GOSS N/A
  • EPS
  • RYAM N/A
  • GOSS N/A
  • Revenue
  • RYAM $1,471,356,000.00
  • GOSS $44,051,000.00
  • Revenue This Year
  • RYAM N/A
  • GOSS N/A
  • Revenue Next Year
  • RYAM $4.65
  • GOSS $16.11
  • P/E Ratio
  • RYAM N/A
  • GOSS N/A
  • Revenue Growth
  • RYAM N/A
  • GOSS N/A
  • 52 Week Low
  • RYAM $3.35
  • GOSS $0.66
  • 52 Week High
  • RYAM $9.60
  • GOSS $3.60
  • Technical
  • Relative Strength Index (RSI)
  • RYAM 30.83
  • GOSS 58.19
  • Support Level
  • RYAM $5.90
  • GOSS $2.21
  • Resistance Level
  • RYAM $6.34
  • GOSS $2.71
  • Average True Range (ATR)
  • RYAM 0.30
  • GOSS 0.16
  • MACD
  • RYAM -0.11
  • GOSS 0.05
  • Stochastic Oscillator
  • RYAM 24.00
  • GOSS 88.07

About RYAM Rayonier Advanced Materials Inc.

Rayonier Advanced Materials Inc is engaged in the production of cellulose specialties, a natural polymer used in the manufacturing of various specialty chemical products, including liquid crystal displays, filters, textiles and performance additives for pharmaceutical, food and other industrial applications. The company's products are used in a variety of applications, including cigarette filters, liquid crystal displays, paints, pharmaceuticals, and food. The company operates in the reportable segments of High Purity Cellulose, Paperboard, and High-Yield Pulp. The key revenue is derived from the High Purity Cellulose segment. Geographically, it derives a majority of its revenue from the United States.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: